MENU
SCTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Scribe Therapeutics (SCTX) Ownership - Who owns Scribe Therapeutics?

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
602.72M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
2.06 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Who owns Scribe Therapeutics? SCTX symbol Ownership - Tickeron.com